Qiang Cao

3.5k total citations · 2 hit papers
149 papers, 2.1k citations indexed

About

Qiang Cao is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Qiang Cao has authored 149 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 44 papers in Surgery and 37 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Qiang Cao's work include Bladder and Urothelial Cancer Treatments (25 papers), Urinary and Genital Oncology Studies (14 papers) and Renal cell carcinoma treatment (12 papers). Qiang Cao is often cited by papers focused on Bladder and Urothelial Cancer Treatments (25 papers), Urinary and Genital Oncology Studies (14 papers) and Renal cell carcinoma treatment (12 papers). Qiang Cao collaborates with scholars based in China, Macao and United States. Qiang Cao's co-authors include Chao Qin, Changjun Yin, Xiaobing Ju, Yuquan Chen, Pengfei Shao, Qi Zhang, Xiaoxin Meng, Yanwei You, Pu Li and Zhengdong Zhang and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Qiang Cao

136 papers receiving 2.1k citations

Hit Papers

Muscle quality index is associated with trouble sleeping:... 2023 2026 2024 2025 2023 2024 20 40 60

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qiang Cao China 26 1.0k 636 459 327 272 149 2.1k
Lili Yu China 28 1.2k 1.2× 549 0.9× 263 0.6× 357 1.1× 359 1.3× 123 2.5k
Yunming Li China 30 724 0.7× 339 0.5× 304 0.7× 243 0.7× 235 0.9× 107 2.1k
Rui Huang China 28 1.2k 1.2× 724 1.1× 482 1.1× 673 2.1× 335 1.2× 178 2.4k
Long Liu China 27 980 1.0× 673 1.1× 732 1.6× 568 1.7× 261 1.0× 136 2.4k
Juan Tan China 25 896 0.9× 371 0.6× 294 0.6× 406 1.2× 219 0.8× 93 1.8k
Zhichao Chen China 29 1.3k 1.3× 679 1.1× 203 0.4× 510 1.6× 234 0.9× 158 3.0k
Fang Liu China 28 741 0.7× 392 0.6× 769 1.7× 620 1.9× 568 2.1× 192 2.7k

Countries citing papers authored by Qiang Cao

Since Specialization
Citations

This map shows the geographic impact of Qiang Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiang Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiang Cao more than expected).

Fields of papers citing papers by Qiang Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiang Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiang Cao. The network helps show where Qiang Cao may publish in the future.

Co-authorship network of co-authors of Qiang Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Qiang Cao. A scholar is included among the top collaborators of Qiang Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiang Cao. Qiang Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cao, Qiang, et al.. (2024). MRI‐Based Machine Learning Radiomics for Preoperative Assessment of Human Epidermal Growth Factor Receptor 2 Status in Urothelial Bladder Carcinoma. Journal of Magnetic Resonance Imaging. 60(6). 2694–2704. 5 indexed citations
3.
Ma, Ze, et al.. (2024). DTASUnet: a local and global dual transformer with the attention supervision U-network for brain tumor segmentation. Scientific Reports. 14(1). 28379–28379. 3 indexed citations
4.
Yang, Xiao, et al.. (2024). Tislelizumab in combination with gemcitabine plus cisplatin as neoadjuvant therapy for lymph node‐positive bladder cancer: Results of a prospective study.. Journal of Clinical Oncology. 42(4_suppl). 619–619. 1 indexed citations
5.
Cao, Qiang, et al.. (2023). The relationship between non-suicidal self-injury and childhood abuse in transgender people: a cross-sectional cohort study. Frontiers in Psychology. 14. 1062601–1062601. 5 indexed citations
6.
You, Yanwei, Yuquan Chen, Yangchang Zhang, et al.. (2023). Mitigation role of physical exercise participation in the relationship between blood cadmium and sleep disturbance: a cross-sectional study. BMC Public Health. 23(1). 1465–1465. 55 indexed citations
7.
Xu, Dengan, Xumei Luo, Xiuling Tian, et al.. (2023). Dissecting pleiotropic functions of the wheat Green Revolution gene Rht-B1b in plant morphogenesis and yield formation. Development. 150(20). 12 indexed citations
8.
Cao, Qiang, Qi Wang, Xinyan Wu, et al.. (2023). A literature review: mechanisms of antitumor pharmacological action of leonurine alkaloid. Frontiers in Pharmacology. 14. 1272546–1272546. 14 indexed citations
9.
Cao, Qiang, Peikun Liu, Kai Li, et al.. (2023). Development and Validation of an MRI‐Based Nomogram for Preoperative Detection of Muscle Invasion in VI‐RADS 3. Journal of Magnetic Resonance Imaging. 60(2). 448–457. 4 indexed citations
10.
Cao, Qiang, et al.. (2022). The Function of Natural Polysaccharides in the Treatment of Ulcerative Colitis. Frontiers in Pharmacology. 13. 927855–927855. 31 indexed citations
11.
Qi, Yuan, Chao Qin, Qiang Cao, et al.. (2018). Polymorphism rs4787951 in IL-4R contributes to the increased risk of renal cell carcinoma in a Chinese population. Gene. 685. 242–247. 2 indexed citations
12.
Cao, Qiang, Bin Huo, Xiaodong Huo, et al.. (2017). Dosimetric study of 3D-printing coplanar template combined with CT-guided 125I seed implantation for treating non-small cell lung cancer. Zhonghua fangshe yixue yu fanghu zazhi. 37(7). 528–532. 2 indexed citations
13.
Liu, Yiyang, Jian Qian, Meiling Bao, et al.. (2015). miR-134 Functions as a Tumor Suppressor in Cell Proliferation and Epithelial-to-Mesenchymal Transition by Targeting KRAS in Renal Cell Carcinoma Cells. DNA and Cell Biology. 34(6). 429–436. 58 indexed citations
14.
Yang, Xiao, Pengchao Li, Jun Tao, et al.. (2014). Association betweenNFKB1−94ins/del ATTG Promoter Polymorphism and Cancer Susceptibility: An Updated Meta-Analysis. International Journal of Genomics. 2014. 1–8. 26 indexed citations
15.
Qin, Chao, Jiarong Chen, Xingrong Ju, et al.. (2014). Variants in angiogenesis-related genes and the risk of clear cell renal cell carcinoma. Mutagenesis. 29(6). 419–425. 14 indexed citations
16.
Yang, Xiao, Pengchao Li, Chao Qin, et al.. (2013). TSP-1-1223 A/G Polymorphism as a Potential Predictor of the Recurrence Risk of Bladder Cancer in a Chinese Population. International Journal of Genomics. 2013. 1–9. 2 indexed citations
17.
Qin, Chao, Li Cui, Qiang Cao, et al.. (2013). Application of the revised Tumour Node Metastasis (TNM) staging system of clear cell renal cell carcinoma in eastern China: advantages and limitations. Asian Journal of Andrology. 15(4). 550–557. 10 indexed citations
18.
Wang, Wei, Yanqin Gao, Meilin Wang, et al.. (2012). Association of Ku70 A-31G Polymorphism and Risk of Renal Cell Carcinoma in a Chinese Population. DNA and Cell Biology. 31(7). 1314–1320. 5 indexed citations
19.
Chen, Jiawei, Yi‐Long Wu, Pengfei Shao, et al.. (2011). Association Between VHL Single Nucleotide Polymorphism (rs779805) and the Susceptibility to Prostate Cancer in Chinese. DNA and Cell Biology. 31(5). 790–796. 7 indexed citations
20.
Zhao, Hu, Chao Qin, Yan Fu, et al.. (2010). hOGG1 Ser326Cys Polymorphism and Renal Cell Carcinoma Risk in a Chinese Population. DNA and Cell Biology. 30(5). 317–321. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026